Literature DB >> 2885493

LHRH analogues and bone loss.

J P Devogelaer, C Nagant de Deuxchaisnes, J Donnez, K Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2885493     DOI： 10.1016/s0140-6736(87)92255-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  Buserelin-mediated osteoporosis: effects of restoring estrogen on bone resorption and whole body calcium content in the rat.

Authors:  A Goulding; E Gold
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

3.  Long-term effects on bone mineral density and bone metabolism of 6 months' treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate.

Authors:  Kazuya Makita; Ken Ishitani; Hiroaki Ohta; Fumi Horiguchi; Shiro Nozawa
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

Review 4.  Osteoporosis prevention and treatment with sex hormone replacement therapy.

Authors:  S Rozenberg; M Kroll; A Pastijn; J Vandromme
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

5.  Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty.

Authors:  G Saggese; S Bertelloni; G I Baroncelli; R Battini; G Franchi
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

6.  Bone loss during gonadotropin-releasing hormone agonist treatment in girls with true precocious puberty is not due to an impairment of calcitonin secretion.

Authors:  G Saggese; S Bertelloni; G I Baroncelli; D Pardi; L Cinquanta
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

7.  Endometrial adenocarcinoma in a 27-year-old woman.

Authors:  Anis Fadhlaoui; Jamel Ben Hassouna; Mohamed Khrouf; Fethi Zhioua; Anis Chaker
Journal:  Clin Med Insights Case Rep       Date:  2010-08-12

8.  Fertility Sparing Treatment in Patients With Early Stage Endometrial Cancer, Using a Combination of Surgery and GnRH Agonist: A Monocentric Retrospective Study and Review of the Literature.

Authors:  Stéphanie Tock; Pascale Jadoul; Jean-Luc Squifflet; Etienne Marbaix; Jean-François Baurain; Mathieu Luyckx
Journal:  Front Med (Lausanne)       Date:  2018-08-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.